Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2016-09-06

FDA Approved: VIIBRYD — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for VIIBRYD (vilazodone hydrochloride) from Allergan, Inc.—updating the drug's labeling. This action falls under labelin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Viibryd (vilazodone)

Snippet

SUPPL AP for VIIBRYD (VILAZODONE HYDROCHLORIDE)